SKYE – skye bioscience, inc. (US:NASDAQ)
Stock Stats
News
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
Skye Bioscience to Present at Upcoming Investment Conferences
Skye Bioscience, Inc. (NASDAQ: SKYE) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $25.00 price target on the stock.
Skye Bioscience, Inc. (OTCMKTS: SKYE) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $25.00 price target on the stock.
Form S-3 Skye Bioscience, Inc.
Form S-3 Skye Bioscience, Inc.
Form 10-Q Skye Bioscience, Inc. For: Mar 31
Form EFFECT Skye Bioscience, Inc.
Form POS AM Skye Bioscience, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.